Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

Deccan Cements Ltd

DECCANCE
Cement

Deccan Cements Ltd is cheap for a reason. The P/E sits at the 22nd percentile of its own range, and the quarters are still getting worse.

The sharpest disagreement: annual EPS moved +279.9% against a −46.4% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (38 weeks in) while the P/E sits at the 22nd percentile of its own 1-year range. Underneath, the last four quarters read deteriorating — profit −118.5% year on year, and 103% of the last 2 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Price
₹574
−46.4% 1Y
P/E
45.4×
22nd pctile
of its own 1-year range
Revenue (Jun 26)
₹219 Cr
+45.7% YoY
Profit (Jun 26)
₹−2.8 Cr
−118.5% YoY
Operating margin
7.7%
−10.8 pp YoY
ROCE
3%
FY26
ROIC
2.5%
vs WACC 12.0% → −9.5 pp
Cash conversion
103%
of profit, last 2 FY
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified. PEG is the exception: the quarterly curve is not drawn at all. PEG asks what is being paid for growth — both sides of that division come from the source that could not be checked, so it is withheld instead of marked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Deccan Cements Ltd trades at ₹574, in a downtrend and 38 weeks into that stage. That is −11.6% against its own 200-day average. It sits at 6% of a 52-week range of ₹545 to ₹1,035. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (23 weeks and counting).

Today the stock is in a downtrend — week 38 of stage 4, confirmed. At ₹574 it trades −11.6% versus its 200-day average and sits at 6% of its 52-week range (₹545–₹1,035).

Sep 26: ₹574 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−11.6% versus the 200-day line, week 38 of stage 4
Price50-day avg200-day avg
S2S4S2S4₹1,171₹989₹806₹623₹441₹574₹649Sep 23Jun 24Mar 25Jan 26Sep 26
S2S4S2S4₹1,171₹989₹806₹623₹441₹574₹649Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (554 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +107% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (23 weeks and counting; last ahead the week of 2026-05-08) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Deccan Cements Ltd trades at 45.4× P/E, near the bottom of its own range — cheaper only 22% of the time. Its long-run median P/E is 169.2×, measured across 0.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 45.4× is near the bottom of its own range — cheaper only 22% of the time, against a long-run median of 169.2× measured over 0.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 45.4× vs a 169.2× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 0.8-year window. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 22% of the time
P/EMedianEPS (TTM) (quarterly)
299.1×₹13.8230.5×₹10.3161.8×₹6.993.1×₹3.424.5×₹0.0×45.40×₹13Oct 25Dec 25Mar 26Jun 26Aug 26
299.1×₹13.8230.5×₹10.3161.8×₹6.993.1×₹3.424.5×₹0.0×45.40×₹13Oct 25Mar 26Aug 26
P/E
45.4×
22nd percentile of 1y

Why the multiple sits where it does: over the past year annual EPS moved +279.9% against a −46.4% price move — earnings outran the price, pushing the multiple DOWN its own range.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

03 · What the price assumes

What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.

Solved at its 13 June 2026 price, Deccan Cements Ltd was paying for profit growth of about 19.8% a year. Profit itself has compounded 262.5% a year over the past 1 years. Today the market pays 45.4× P/E, the 22nd percentile of its own 1-year range.

What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is below what this company has actually delivered.

How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.

04 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Deccan Cements Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 5 quarters across 0 curves, on partial evidence.

Growth, year by year: revenue +20.7% in FY26, profit +262.5% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
21.9%281%21.3%276%20.7%271%20.1%266%19.5%261%%%20.7%262.5%FY25FY26
21.9%281%21.3%276%20.7%271%20.1%266%19.5%261%%%20.7%262.5%FY25FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfitEPS
87%338%60%201%34%65%6.9%−71%−20%−207%%%45.7%−118.5%−48.2%Jun 24Jun 25Jun 26
87%338%60%201%34%65%6.9%−71%−20%−207%%%45.7%−118.5%−48.2%Jun 24Jun 25Jun 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
4.2%3.6%3.0%2.4%1.8%%3%FY26
4.2%3.6%3.0%2.4%1.8%%3%FY26

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+20.7%
Profit+262.5%
EPS+279.9%
Share price−46.4%+0.4%−4.7%+1.8%
Revenue YoY (Jun 26)
+45.7%
latest quarter vs a year ago
Profit YoY (Jun 26)
−118.5%
latest quarter vs a year ago
Revenue 10y
20.7%
long-run compound pace
05 · 4-Factor Sector Score

4-Factor Sector Score

39.5/100 — rank 22 of 26 in Cement · 80% evidence confidence

Deccan Cements Ltd scores 39.5 out of 100 against the 26 companies it is compared with in Cement, ranking 22. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 13.9 + 7.4 + 9.9 + 8.3 = 39.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

06 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Deccan Cements Ltd reported ₹219 Cr of revenue in the Jun 26 quarter, +45.7% year on year. That is the 4th straight quarter of year-on-year growth. Over 1 years it has compounded at 20.7% a year. The last full year, FY26, came in at ₹636 Cr. The last four reported quarters add to ₹704 Cr.

FY26 revenue came in at ₹636 Cr (+20.7% on the year), capping 1 years at 20.7% compound. The latest quarter (Jun 26) printed ₹219 Cr, +45.7% year on year — the 4th consecutive quarter of year-over-year growth.

FY26 revenue ₹636 Cr (+20.7% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 2-year window. A bar is red when it is lower than the year before.
20.7% a year over 1 years
RevenueYoY growth
68721.9%51521.3%34320.7%17220.1%019.5%₹ Cr%₹63620.7%FY25FY26
68721.9%51521.3%34320.7%17220.1%019.5%₹ Cr%₹63620.7%FY25FY26
Jun 26: ₹219 Cr (+45.7% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
4th straight quarter of growth
Revenue (quarterly)YoY growth
23787%17860%11834%596.9%0−20%₹ Cr%₹21945.7%Jun 24Jun 25Jun 26
23787%17860%11834%596.9%0−20%₹ Cr%₹21945.7%Jun 24Jun 25Jun 26

Pace check: the last four quarters averaged +38.9% growth against the decade's 20.7% — the current year is running faster than its own long-run rate.

07 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Deccan Cements Ltd's operating margin is 7.7% in the Jun 26 quarter, −10.8 percentage points against the same quarter a year ago.

The latest quarter's operating margin is 7.7%, −10.8 pp against the same quarter a year ago. Across 2 fiscal years the operating margin has ranged 7.0%–12.0%.

🚨 Why the margin moved: operating margin went −10.8 pp year on year while gross margin went −8.8 pp — the loss came mostly from the gross line: input costs and pricing.

FY26: 12.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 2-year window.
within a 7.0–12.0% band over 2 years
operating marginYoY change (pp)
12%6.2%11%5.6%9.5%5.0%8.1%4.4%6.6%3.8%%%12%5%FY25FY26
12%6.2%11%5.6%9.5%5.0%8.1%4.4%6.6%3.8%%%12%5%FY25FY26
Jun 26: 7.7% operating margin (−10.8 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
20%14%15%7.7%10%0.9%5.3%−5.9%0.5%−13%%%7.7%−10.8%Jun 24Jun 25Jun 26
20%14%15%7.7%10%0.9%5.3%−5.9%0.5%−13%%%7.7%−10.8%Jun 24Jun 25Jun 26
08 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Deccan Cements Ltd posted a net loss of ₹2.8 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹29.0 Cr. The 1-year compound rate is 262.5%. That loss is 1.3% of the quarter's revenue. The same quarter a year earlier earned ₹15.3 Cr. 3 of the last 9 reported quarters were loss-making.

Jun 26 profit was ₹−2.8 Cr, −118.5% year on year. On the full year, FY26 printed ₹29.0 Cr (+262.5%), and the 1-year compound rate is 262.5%.

FY26 profit ₹29.0 Cr (+262.5% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 2-year window. A bar is red when it is lower than the year before.
262.5% a year over 1 years
Net profitYoY growth
31263.7%23263.1%16262.5%8261.9%0261.3%₹ Cr%₹29262.5%FY25FY26
31263.7%23263.1%16262.5%8261.9%0261.3%₹ Cr%₹29262.5%FY25FY26
Jun 26: ₹−2.8 Cr (−118.5% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
17496%11317%6139%0−40%−6−218%₹ Cr%₹−3−118.5%Jun 24Jun 25Jun 26
17496%11317%6139%0−40%−6−218%₹ Cr%₹−3−118.5%Jun 24Jun 25Jun 26

🚨 Why profit moved: revenue contributed +45.7% and the margin −10.8 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −109.4% vs revenue +38.9%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

09 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 2 fiscal years 103% of Deccan Cements Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹76.0 Cr of operating cash against ₹29.0 Cr of profit. After ₹184 Cr of capital spending, ₹−108 Cr was left as free cash.

FY26: operating cash of ₹76.0 Cr against reported profit of ₹29.0 Cr, leaving free cash of ₹−108 Cr after ₹184 Cr of capital spending. Across the last 2 fiscal years the conversion rate is 103% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹76.0 Cr vs profit ₹29.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 2-year window, annual resolution.
103% of 2-year profit arrived as cash
Operating cashNet profitFree cash
9137−16−69−123₹ Cr₹76₹29₹−108FY25FY26
9137−16−69−123₹ Cr₹76₹29₹−108FY25FY26
FY26: CFO = 262% of profit (three-year rate 103%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
321%107%−107%−320%−534%%262%FY25FY26
321%107%−107%−320%−534%%262%FY25FY26

Why conversion sits at 103%: the cash cycle tightened 173 days between FY25 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.

Router verdict: the bigger cash user is investment — capital spending ran 5.1× depreciation over three years, so the next section's job is to check what that build-out is buying.

10 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Deccan Cements Ltd's cash conversion cycle runs 213 days in FY26, down from 386 days in FY25. Capital spending ran ₹184 Cr over the last 1 years. At FY26 sales of ₹636 Cr each day of that cycle holds about ₹1.7 Cr, so roughly ₹371 Cr sits inside the business at any moment.

FY26: debtors at 28 days, inventory at 382 days — roughly 12.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 213 days, tighter than FY25's 386.

The full loop: cash goes out to suppliers and production on day 0; stock waits 382 days to sell; customers pay about 28 days after that; and suppliers themselves are paid at 197 days — netting out to the 213-day cycle.

In money terms: at FY26 sales of ₹636 Cr, each day of the cycle holds about ₹1.7 Cr — so the 213-day loop keeps roughly ₹371 Cr sitting inside the business at any moment.

FY26: a 213-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 2-year window.
−173 days vs FY25
Cash cycleInventory daysDebtor daysPayable days
582433285136−13days213d382d28d197dFY25FY26
582433285136−13days213d382d28d197dFY25FY26

On the investment side: capital spending of ₹184 Cr over the last 1 fiscal years against ₹36.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹3.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹184 Cr, work-in-progress ₹3.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
19914999500₹ Cr₹184₹3FY26
19914999500₹ Cr₹184₹3FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

11 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Deccan Cements Ltd earns a ROCE of 3% in FY26. Return on invested capital clears the cost of that capital by −9.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 4.6% net margin on 0.37× asset turns.

FY26 ROCE is 3%.

🚨 Why the return is what it is — the wiring (FY26): 4.6% net margin × 0.37× asset turns × 2.28× balance-sheet leverage ≈ 3.9% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 2.5% − 12.0% = a −9.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 3% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 1-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the full ladder
ROCEROIC (annual)WACC
13%10%7.3%4.5%1.7%%3%2.5%FY26
13%10%7.3%4.5%1.7%%3%2.5%FY26
Q4 FY26: ROCE 3.0% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
13%9.5%6.2%2.8%−0.6%%3%2.5%Q1 FY24Q2 FY25Q4 FY26
13%9.5%6.2%2.8%−0.6%%3%2.5%Q1 FY24Q2 FY25Q4 FY26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Deccan Cements Ltd carries total debt of ₹753 Cr against shareholder equity of ₹751 Cr as of Mar 26, a debt-to-equity of 1.00. On the annual view that ratio went from 0.26 in FY22 to 1.00 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹753 Cr against shareholder equity of ₹751 Cr — a debt-to-equity of 1.00. On the annual view, debt-to-equity went from 0.26 (FY22) to 1.00 (FY26). Read the returns on this page with that leverage in mind.

FY26: debt ₹753 Cr at 1.00× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
8131.1×6100.8×4070.6×2030.4×00.2×₹ Cr×₹7531.00×FY22FY24FY26
8131.1×6100.8×4070.6×2030.4×00.2×₹ Cr×₹7531.00×FY22FY24FY26
Mar 26: debt ₹753 Cr, debt-to-equity 1.00 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
8211.1×6160.9×4100.7×2050.5×00.3×₹ Cr×₹7531.00×Jun 23Sep 24Mar 26
8211.1×6160.9×4100.7×2050.5×00.3×₹ Cr×₹7531.00×Jun 23Sep 24Mar 26
13 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions added 3.7 points of Deccan Cements Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 14.7% of the company. Domestic institutions moved −0.1 points over the same window, to 0.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: +3.7 points over 8 quarters to 14.7%; Domestic institutions: −0.1 points over 8 quarters to 0.8%; Promoters: +0.0 points over 8 quarters to 56.2%.

Why the register moved: foreign institutions drove it (+3.7 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
61%45%28%12%−3.8%%56.2%14.3%0.8%28.7%Mar 24Mar 25Mar 26
61%45%28%12%−3.8%%56.2%14.3%0.8%28.7%Mar 24Mar 25Mar 26
Foreign institutions added 3.7 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
61%45%28%12%−4.0%%56.2%14.7%0.8%28.3%Jun 23Dec 24Jun 26
61%45%28%12%−4.0%%56.2%14.7%0.8%28.3%Jun 23Dec 24Jun 26
14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Deccan Cements Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

15 · Related companies · Cement
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Star Cement LtdSTARCEMENT 69.7/100Favorable setup94% evidence BASING 25.6/35 Revenue 14.5% · PAT 55.1% · OPM change -4 pp 100% evidence 20.2/25 ROCE 16.6% · OPM 21% 100% evidence 11.0/20 P/E 20.9× · PEG 1.11 100% evidence 12.9/20 RS sector 13.8% · RS bench -10.3% · 1Y -33.2%0 of 10 weeks ahead 70% evidence
Exact sum: 25.6 + 20.2 + 11 + 12.9 = 69.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2NCL Industries LtdNCLIND 66.9/100Favorable setup87% evidence ASLEEP 23.2/35 Revenue 3.7% · PAT 100% · OPM change -3 pp 95% evidence 18.1/25 ROCE 14.6% · OPM 12% 95% evidence 14.9/20 P/E 6.4× · PEG — 50% evidence 10.7/20 RS sector 3.2% · RS bench -5.3% · 1Y -18.2%2 of 12 weeks ahead 100% evidence
Exact sum: 23.2 + 18.1 + 14.9 + 10.7 = 66.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Rain Industries LtdRAIN 64.7/100Mixed-positive evidence75% evidence LEADER 28.4/35 Revenue 17% · PAT 100% · OPM change 5 pp 95% evidence 10.5/25 ROCE 8.3% · OPM 19% 76% evidence 10.8/20 P/E 13.5× · PEG — 15% evidence 15.0/20 RS sector 53% · RS bench 41.8% · 1Y 55.9%11 of 12 weeks ahead 100% evidence
Exact sum: 28.4 + 10.5 + 10.8 + 15 = 64.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4UltraTech Cement LtdULTRACEMCO 63.5/100Mixed-positive evidence76% evidence TURNING 23.1/35 Revenue 17.2% · PAT 26.7% · OPM change -1 pp 95% evidence 17.1/25 ROCE 12.7% · OPM 20% 76% evidence 9.6/20 P/E 37.6× · PEG — 50% evidence 13.7/20 RS sector 17% · RS bench -5.5% · 1Y -12.7%0 of 10 weeks ahead 70% evidence
Exact sum: 23.1 + 17.1 + 9.6 + 13.7 = 63.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
5Mangalam Cement LtdMANGLMCEM 63.4/100Mixed-positive evidence100% evidence TURNING 18.1/35 Revenue 0.5% · PAT 90% · OPM change -5 pp 100% evidence 10.5/25 ROCE 11% · OPM 12% 100% evidence 15.2/20 P/E 21.7× · PEG 0.6 100% evidence 19.6/20 RS sector 32.9% · RS bench 23% · 1Y 33.8%8 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 10.5 + 15.2 + 19.6 = 63.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Orient Cement LtdORIENTCEM 58.1/100Mixed-positive evidence93% evidence BASING 17.9/35 Revenue -12.1% · PAT -19.3% · OPM change 3 pp 100% evidence 16.9/25 ROCE 16.5% · OPM 24% 100% evidence 16.1/20 P/E 12.1× · PEG 0.25 65% evidence 7.2/20 RS sector -11.4% · RS bench -19.2% · 1Y -43.9%0 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 16.9 + 16.1 + 7.2 = 58.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7HeidelbergCement India LtdHEIDELBERG 55.7/100Mixed-positive evidence100% evidence TURNING 15.7/35 Revenue 6.6% · PAT 2.6% · OPM change -4 pp 100% evidence 14.8/25 ROCE 14.7% · OPM 11% 100% evidence 13.2/20 P/E 27.9× · PEG 0.83 100% evidence 12.0/20 RS sector -0.9% · RS bench -9.3% · 1Y -30.1%0 of 12 weeks ahead 100% evidence
Exact sum: 15.7 + 14.8 + 13.2 + 12 = 55.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
8Dalmia Bharat LtdDALBHARAT 55.1/100Mixed-positive evidence94% evidence BREAKING OUT 14.1/35 Revenue 7.6% · PAT 0.4% · OPM change -3 pp 100% evidence 13.2/25 ROCE 7.6% · OPM 21% 100% evidence 15.1/20 P/E 29.8× · PEG 0.72 100% evidence 12.7/20 RS sector 12.6% · RS bench -9.4% · 1Y -27.5%1 of 10 weeks ahead 70% evidence
Exact sum: 14.1 + 13.2 + 15.1 + 12.7 = 55.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
9JSW Cement LtdJSWCEMENT 51.9/100Thin evidence · provisional52% evidence ASLEEP 19.2/35 Revenue 15.6% · PAT 100% · OPM change -5 pp 71% evidence 11.8/25 ROCE 11.1% · OPM 16% 76% evidence 10.6/20 P/E 20.6× · PEG — 15% evidence 10.3/20 RS sector — · RS bench -4.9% · 1Y -20.8%3 of 10 weeks ahead 25% evidence
Exact sum: 19.2 + 11.8 + 10.6 + 10.3 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Nuvoco Vistas Corporation LtdNUVOCO 49.5/100Mixed-negative evidence87% evidence TURNING 21.8/35 Revenue 9.5% · PAT 100% · OPM change 0 pp 100% evidence 10.2/25 ROCE 7% · OPM 18% 100% evidence 4.8/20 P/E 28.4× · PEG 8.14 65% evidence 12.7/20 RS sector 3.6% · RS bench -2.8% · 1Y -28.8%5 of 10 weeks ahead 70% evidence
Exact sum: 21.8 + 10.2 + 4.8 + 12.7 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11J K Cements LtdJKCEMENT 48.1/100Mixed-negative evidence94% evidence TURNING 11.9/35 Revenue 15.9% · PAT -7.1% · OPM change -5 pp 100% evidence 16.7/25 ROCE 15.1% · OPM 16% 100% evidence 8.0/20 P/E 38.3× · PEG 1.46 100% evidence 11.5/20 RS sector 10.4% · RS bench -12.1% · 1Y -27%0 of 10 weeks ahead 70% evidence
Exact sum: 11.9 + 16.7 + 8 + 11.5 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Prism Johnson LtdPRSMJOHNSN 47.2/100Mixed-negative evidence61% evidence BASING 18.1/35 Revenue 4.8% · PAT 100% · OPM change 2 pp 71% evidence 6.9/25 ROCE 5.9% · OPM 12% 76% evidence 9.2/20 P/E 48.6× · PEG — 15% evidence 13.0/20 RS sector 14.3% · RS bench -10.5% · 1Y -22.4%0 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 6.9 + 9.2 + 13 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13JK Lakshmi Cement LtdJKLAKSHMI 44.8/100Mixed-negative evidence69% evidence BASING 14.6/35 Revenue 8.7% · PAT 0.5% · OPM change -4 pp 95% evidence 14.1/25 ROCE 12% · OPM 14% 76% evidence 10.7/20 P/E 16.3× · PEG — 15% evidence 5.4/20 RS sector -8.2% · RS bench -25.2% · 1Y -45.5%0 of 10 weeks ahead 70% evidence
Exact sum: 14.6 + 14.1 + 10.7 + 5.4 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Birla Corporation LtdBIRLACORPN 44.5/100Mixed-negative evidence94% evidence BASING 18.6/35 Revenue 3.9% · PAT 44.6% · OPM change -1 pp 100% evidence 11.0/25 ROCE 9.8% · OPM 13% 100% evidence 9.8/20 P/E 11.4× · PEG 3.92 100% evidence 5.1/20 RS sector -14% · RS bench -17.8% · 1Y -35.5%0 of 9 weeks ahead 70% evidence
Exact sum: 18.6 + 11 + 9.8 + 5.1 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Shree Cement LtdSHREECEM 44.2/100Mixed-negative evidence100% evidence ASLEEP 15.4/35 Revenue 12.6% · PAT 9.9% · OPM change -5 pp 100% evidence 13.3/25 ROCE 10.3% · OPM 20% 100% evidence 9.5/20 P/E 50× · PEG 0.96 100% evidence 6.0/20 RS sector -4.1% · RS bench -12.1% · 1Y -24.9%3 of 12 weeks ahead 100% evidence
Exact sum: 15.4 + 13.3 + 9.5 + 6 = 44.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16India Cements LtdINDIACEM 44.1/100Mixed-negative evidence75% evidence ASLEEP 21.0/35 Revenue 7% · PAT 100% · OPM change 7 pp 74% evidence 3.7/25 ROCE 1.2% · OPM 15% 100% evidence 6.3/20 P/E 79.6× · PEG — 50% evidence 13.1/20 RS sector 20% · RS bench -12% · 1Y -12.2%0 of 10 weeks ahead 70% evidence
Exact sum: 21 + 3.7 + 6.3 + 13.1 = 44.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17ACC LtdACC 42.6/100Mixed-negative evidence94% evidence BASING 9.4/35 Revenue 11.6% · PAT -21.1% · OPM change -5 pp 100% evidence 9.8/25 ROCE 11.2% · OPM 8% 100% evidence 16.8/20 P/E 12.3× · PEG 0.92 100% evidence 6.6/20 RS sector -6.7% · RS bench -18.5% · 1Y -31.8%0 of 10 weeks ahead 70% evidence
Exact sum: 9.4 + 9.8 + 16.8 + 6.6 = 42.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
18K C P LtdKCP 42.6/100Mixed-negative evidence81% evidence BASING 7.8/35 Revenue 6.5% · PAT -17.1% · OPM change -8 pp 95% evidence 14.3/25 ROCE 12.2% · OPM 8% 95% evidence 13.2/20 P/E 11.8× · PEG — 50% evidence 7.3/20 RS sector -14% · RS bench -3.9% · 1Y -20.3%1 of 11 weeks ahead 70% evidence
Exact sum: 7.8 + 14.3 + 13.2 + 7.3 = 42.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
19Shiva Cement LtdSHIVACEM 41.0/100Thin evidence · provisional58% evidence 23.0/35 Revenue 49.5% · PAT 22.5% · OPM change 13.9 pp 71% evidence 4.5/25 ROCE -1.4% · OPM 12% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 3.5/20 RS sector -27.5% · RS bench -20.8% · 1Y -44.7%0 of 12 weeks ahead 70% evidence
Exact sum: 23 + 4.5 + 10 + 3.5 = 41 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20The Ramco Cements LtdRAMCOCEM 40.6/100Mixed-negative evidence94% evidence BASING 18.3/35 Revenue 8.6% · PAT 100% · OPM change -6 pp 100% evidence 9.2/25 ROCE 6.1% · OPM 13% 100% evidence 1.1/20 P/E 107× · PEG 4.14 100% evidence 12.0/20 RS sector 11.1% · RS bench -11.1% · 1Y -19%0 of 10 weeks ahead 70% evidence
Exact sum: 18.3 + 9.2 + 1.1 + 12 = 40.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Ambuja Cements LtdAMBUJACEM 40.0/100Mixed-negative evidence82% evidence BASING 10.6/35 Revenue 7.1% · PAT -5.9% · OPM change -2 pp 95% evidence 11.0/25 ROCE 5.6% · OPM 17% 76% evidence 12.4/20 P/E 20.7× · PEG — 50% evidence 6.0/20 RS sector -10.3% · RS bench -17.9% · 1Y -30.9%0 of 12 weeks ahead 100% evidence
Exact sum: 10.6 + 11 + 12.4 + 6 = 40 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Deccan Cements Ltdthis pageDECCANCE 39.5/100Mixed-negative evidence80% evidence TURNING 13.9/35 Revenue 39.4% · PAT -48.2% · OPM change -10.8 pp 95% evidence 7.4/25 ROCE 3.3% · OPM 7.7% 95% evidence 9.9/20 P/E 28.1× · PEG — 15% evidence 8.3/20 RS sector -10.4% · RS bench -18.5% · 1Y -47%0 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 7.4 + 9.9 + 8.3 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Sagar Cements LtdSAGCEM 35.9/100Mixed-negative evidence72% evidence ASLEEP 20.0/35 Revenue 13.4% · PAT 79.7% · OPM change -8 pp 95% evidence 5.0/25 ROCE 2% · OPM 10% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 0.9/20 RS sector -16.6% · RS bench -23.7% · 1Y -50.3%1 of 12 weeks ahead 100% evidence
Exact sum: 20 + 5 + 10 + 0.9 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24BIGBLOC Construction LtdBIGBLOC 34.2/100Adverse evidence72% evidence BASING 18.6/35 Revenue 33.5% · PAT 11.3% · OPM change 5.6 pp 71% evidence 6.0/25 ROCE 1.9% · OPM 7.9% 95% evidence 8.5/20 P/E 344× · PEG — 15% evidence 1.1/20 RS sector -15.2% · RS bench -22.3% · 1Y -33.1%1 of 12 weeks ahead 100% evidence
Exact sum: 18.6 + 6 + 8.5 + 1.1 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Saurashtra Cement LtdSAURASHCEM 34.1/100Adverse evidence80% evidence ASLEEP 14.5/35 Revenue 7.9% · PAT -52.1% · OPM change -3.7 pp 95% evidence 5.2/25 ROCE 2.5% · OPM 4.5% 95% evidence 9.4/20 P/E 38× · PEG — 15% evidence 5.0/20 RS sector -15.8% · RS bench -23.5% · 1Y -53.7%0 of 12 weeks ahead 100% evidence
Exact sum: 14.5 + 5.2 + 9.4 + 5 = 34.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Shree Digvijay Cement Co. LtdSHREDIGCEM 32.1/100Adverse evidence81% evidence BASING 11.9/35 Revenue 19.6% · PAT -35% · OPM change -3.5 pp 95% evidence 8.4/25 ROCE 6.4% · OPM 8.7% 95% evidence 5.5/20 P/E 56.3× · PEG — 50% evidence 6.3/20 RS sector -12.4% · RS bench -10.6% · 1Y -24.1%1 of 10 weeks ahead 70% evidence
Exact sum: 11.9 + 8.4 + 5.5 + 6.3 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Deccan Cements Ltd's share price today?

Deccan Cements Ltd trades at ₹574, −46.4% over the past year. The company is valued at ₹804 Cr. The stock sits at 6% of its 52-week range of ₹545–₹1,035, −11.6% versus its 200-day average. On the tape, the price is in a downtrend, 38 weeks in. — as of 11 September 2026.

What were Deccan Cements Ltd's latest quarterly results?

Deccan Cements Ltd reported revenue of ₹219 Cr and a net loss of ₹2.8 Cr for the Jun 26 quarter. Revenue rose 45.7% and profit fell 118.5% year on year. Earnings per share were ₹−2.03. The operating margin was 7.7%, 10.8 pp lower than a year earlier. — as of 11 September 2026.

What is Deccan Cements Ltd's revenue?

Deccan Cements Ltd reported revenue of ₹219 Cr in the Jun 26 quarter, +45.7% year on year. For the full FY26 fiscal year, revenue was ₹636 Cr (+20.7%). Over the last 1 years revenue compounded at 20.7% a year. — as of 11 September 2026.

What is Deccan Cements Ltd's profit?

Deccan Cements Ltd earned ₹−2.8 Cr of net profit in the Jun 26 quarter, −118.5% year on year. Full-year FY26 profit was ₹29.0 Cr. The operating margin ran 7.7% in the latest quarter. — as of 11 September 2026.

What is Deccan Cements Ltd's market cap?

Deccan Cements Ltd's market capitalisation is ₹804 Cr at a share price of ₹574. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is Deccan Cements Ltd's P/E ratio?

Deccan Cements Ltd trades at a P/E of 45.4×, at the 22nd percentile of its own 1-year range, against a long-run median of 169.2×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does Deccan Cements Ltd pay a dividend?

Yes — Deccan Cements Ltd's dividend payout was 2% of profit in FY26, and it recorded a payout in each of its last 2 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is Deccan Cements Ltd overvalued?

On its own history, Deccan Cements Ltd looks cheap: its P/E of 45.4× has been cheaper only 22% of the time in 1 years (long-run median 169.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is Deccan Cements Ltd growing?

Not right now — Deccan Cements Ltd's latest numbers are shrinking: latest-quarter revenue +45.7% year on year, profit −118.5%, and the margin −10.8 pp at 7.7%. The 1-year compound rates are 20.7% (revenue) and 262.5% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.

How is Deccan Cements Ltd performing?

Deccan Cements Ltd is in a downtrend, 38 weeks in. Its latest quarter's revenue rose 45.7% and profit fell 118.5% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 23 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

Is Deccan Cements Ltd in an uptrend?

No — the price is in a downtrend (week 38 of stage 4), trading −11.6% versus its 200-day average and at 6% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is Deccan Cements Ltd beating the market?

Not lately — on a trailing-13-week view Deccan Cements Ltd is currently behind the NIFTY 500 (23 weeks and counting; last ahead the week of 2026-05-08), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +107% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.

Will Deccan Cements Ltd's share price go up?

This page publishes no price forecast for Deccan Cements Ltd. What it measures instead: the share price is ₹574, the price is in a downtrend 38 weeks in. Its P/E of 45.4× sits at the 22nd percentile of its own 1-year range. — as of 11 September 2026.

Who owns Deccan Cements Ltd?

Promoters hold 56.2% of Deccan Cements Ltd, foreign institutions 14.7%, domestic institutions 0.8% and the public 28.3% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 3.7 points over 8 quarters. — as of 11 September 2026.

Does Deccan Cements Ltd have too much debt?

It is moderate — Deccan Cements Ltd's debt-to-equity is 1.00, and operating profit covers the interest bill 3×. FY26 borrowings were ₹753 Cr against equity of ₹751 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.

What is Deccan Cements Ltd's capex?

Deccan Cements Ltd spent ₹184 Cr on capital expenditure over the last 1 fiscal year, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹184 Cr, with ₹3.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is Deccan Cements Ltd's cash flow?

Deccan Cements Ltd generated ₹76.0 Cr of operating cash flow in FY26 and ₹−108 Cr of free cash flow after ₹184 Cr of capital spending. Reported profit that year was ₹29.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is Deccan Cements Ltd's profit real cash?

Yes — over the last 2 fiscal years, 103% of Deccan Cements Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹76.0 Cr against reported profit of ₹29.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is Deccan Cements Ltd in its business cycle?

Deccan Cements Ltd's FY26 operating margin was 12.0%, against a 2-year band of 7.0%–12.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 7.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What growth does Deccan Cements Ltd's price assume?

At its price on 13 June 2026, Deccan Cements Ltd was priced for profit growth of about 19.8% a year. Profit itself has compounded 262.5% a year over the past 1 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.

What could break the Deccan Cements Ltd story?

The sharpest disagreement: annual EPS moved +279.9% against a −46.4% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is Deccan Cements Ltd a stock worth studying right now?

This is not investment advice. The machine read: Deccan Cements Ltd is cheap for a reason. The P/E sits at the 22nd percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI